NASDAQ:GENE
Genetic Technologies Ltd Stock News
$2.36
+0.0400 (+1.72%)
At Close: May 01, 2024
Mid-Day Market Update: Dow Jumps Over 600 Points; BioLineRx Shares Plunge
04:21pm, Tuesday, 26'th May 2020Mid-Morning Market Update: Markets Open Higher; AutoZone Beats Q3 Expectations
02:16pm, Tuesday, 26'th May 2020Genetic Technologies Announces Pricing of $8.0 Million Public Offering, $2 Per Share
01:23pm, Tuesday, 26'th May 2020Genetic Technologies Announces Pricing of $8.0 Million Public Offering
01:22pm, Tuesday, 26'th May 2020
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced that it has priced a public offering of 4,000,
Genetic Technologies Announces Pricing of $8.… Million Public Offering
12:00am, Tuesday, 26'th May 2020Genetic Technologies Provides Operational Update - Successful Prototype Polygenic Risk Score for COVID-19 Created
08:05pm, Friday, 22'nd May 2020
To accompany that process, the Company will be working with its Consumer Initiated Testing (CIT) platform supplier to generate online product content to support sales activities in the USA. Leveragin
Genetic Technologies Provides Operational Update - Successful Prototype Polygenic Risk Score ...
12:00am, Friday, 22'nd May 2020Genetic Technologies - Accelerated development of new COVID-19 Polygenic Risk Test for Risk of Developing Life-Threatening Complications
01:15pm, Wednesday, 20'th May 2020
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is to commence accelerating development of a polygenic risk score (PRS) test to predict an individual’s risk of developing life-threatening comp
